Deerfield Partners, L.P., 10% Owner at ANTARES PHARMA, INC. (ATRS), sold 499,895 shares at $2.41 ($1.2M) on 2015-06-19, disclosed to the SEC on 2015-06-23.
Open-market sale of $1.2M ATRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 22,190 | $53K | 4.5% |
| 2 | $2.41 | 52,518 | $127K | 10.6% |
| 3 | $2.41 | 66,842 | $161K | 13.5% |
| 4 | $2.41 | 27,666 | $67K | 5.6% |
| 5 | $2.41 | 65,479 | $158K | 13.2% |
| 6 | $2.41 | 83,338 |
| $201K |
| 16.8% |
| 7 | $2.35 | 28,510 | $67K | 5.6% |
| 8 | $2.35 | 67,475 | $159K | 13.3% |
| 9 | $2.35 | 85,877 | $202K | 16.9% |
| Total | $2.39 avg | 499,895 | $1.2M | 100% |
| Filing → |
| ASPX | BUY | 2015-01-28 | $84.8M | — | Filing → |
| RIGL | BUY | 2011-06-07 | $5.2M | — | Filing → |
| MDCO | SELL | 2011-04-01 | $4.6M | — | Filing → |